New Cardiovascular Drugs: Patterns of Use and Association with Non-Drug Health Expenditures
The potential role of new drugs in reducing expenditures for non-drug health services has received considerable attention in recent policy debates. We estimate expenditure models to determine whether the use of newer drugs to treat cardiovascular conditions is associated with lower (or higher) non-d...
Saved in:
Main Authors: | G. Edward Miller (Author), John F. Moeller (Author), Randall S. Stafford (Author) |
---|---|
Format: | Book |
Published: |
SAGE Publishing,
2005-11-01T00:00:00Z.
|
Subjects: | |
Online Access: | Connect to this object online. |
Tags: |
Add Tag
No Tags, Be the first to tag this record!
|
Similar Items
-
On "New Cardiovascular Drugs: Patterns of Use and Association with Non-Drug Health Expenditures"
by: Frank R. Lichtenberg Ph.D
Published: (2006) -
Authors' Response
by: G. Edward Miller Ph.D, et al.
Published: (2006) -
Drugs with the highest drug expenditure in the Republic of Serbia
by: Milijašević Boris Ž., et al.
Published: (2023) -
Drug utilization and expenditure of anticancer drugs for breast cancer
by: Bander Balkhi, et al.
Published: (2020) -
The influences of Taiwan's generic grouping price policy on drug prices and expenditures: Evidence from analysing the consumption of the three most-used classes of cardiovascular drugs
by: Chen Likwang, et al.
Published: (2008)